Pfizer Inc
NYSE: PFE
$26.17
+$0.52 (+2.0%)
Closing Price on November 25, 2024
PFE Articles
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Published:
Last Updated:
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting their latest results in the coming week.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by the most shorted stocks traded on the New York Stock Exchange, overall short sellers...
Published:
Last Updated:
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Published:
Last Updated:
Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.
Published:
Last Updated:
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The bull market is now eight years old, and markets still keep on hitting new highs. How have the short sellers been reacting to this pricey market?
Published:
Last Updated:
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
Published:
Last Updated: